Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Revenue

    Back to Income Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹11,583 Cr₹12,305 Cr₹10,944 Cr₹10,641 Cr₹9,865 Cr

What is the latest Revenue of GLENMARK PHARMACEUTICALS ?

The latest Revenue ratio of GLENMARK PHARMACEUTICALS is ₹11,583 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹11,583 Cr
Mar2023₹12,305 Cr
Mar2022₹10,944 Cr
Mar2021₹10,641 Cr
Mar2020₹9,865 Cr

How is Revenue of GLENMARK PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2024 ₹11,583 Cr
-5.86
Mar2023 ₹12,305 Cr
12.44
Mar2022 ₹10,944 Cr
2.85
Mar2021 ₹10,641 Cr
7.86
Mar2020 ₹9,865 Cr -

Compare Revenue of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,513.6 Cr -3.5% 25% 50.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,991.0 Cr -0.1% 1.3% 5% Stock Analytics
DIVIS LABORATORIES ₹175,720.0 Cr -1.7% 0.5% 47.2% Stock Analytics
CIPLA ₹120,133.0 Cr 0.4% -1.5% -1.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹118,994.0 Cr -0.2% 9% 13.3% Stock Analytics
DR REDDYS LABORATORIES ₹105,562.0 Cr 0.5% -5.7% -9.1% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-3.5%

25%

50.1%

SENSEX

-0.1%

0.2%

2.1%


You may also like the below Video Courses